RemeGen was cofounded in 2008 by Mr. Weidong Wang, founder of Rongchang Pharmaceuticals, a leading traditional Chinese medicine company in China, and Dr. Jianmin Fang, a Canadian-American scientist. Headquartered in the coastal city of Yantai, Shandong Province of China, RemeGen has research labs and offices throughout China and the United States. RemeGen is committed to the discovery, development and commercialization of innovative and differentiated biologic drugs of significant clinical value in the key therapeutic areas of autoimmune, oncology and ophthalmic diseases.
Our mission is to discover, develop, and deliver innovative biologic drugs for major diseases in the autoimmune, oncology and ophthalmology spaces to fulfill the unmet medical needs of patients worldwide.
We aspire to be a leader within the global biopharmaceutical industry.
|
Advice in respect of our business strategies and objectives
|
|
Academic updates and technical insights relevant to our research and development plans
|
|
Recommendations relating to innovative drug targets, mechanisms and modalities
|
|
Advice on new drug discovery projects
|
|
Biopharmaceutical market data and intelligence
|
